SOLACE Trial - A Phase 3 Trial in Subjects With Non-infectious Anterior-uveitis.

Non-infectious Anterior Uveitis Clinical Trial

Official title:
A Phase 3, Randomized, Double-masked, Vehicle-controlled Trial to Evaluate the Safety and Efficacy of ADX-102 Ophthalmic Solution in Subjects With Non-infectious Anterior-uveitis.

Status Completed

Clinical Trial Summary

A Phase 3, randomized, double-masked, vehicle-controlled trial to evaluate the safety and efficacy of ADX-102 ophthalmic solution in Subjects with non-infectious anterior-uveitis.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03131154
Study type	Interventional
Source	Aldeyra Therapeutics, Inc.
Contact
Status	Completed
Phase	Phase 3
Start date	April 26, 2017
Completion date	April 26, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05042609` - A Study of TRS01 in Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic Glaucoma	Phase 3
Completed	`NCT02309385` - Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis	Phase 1/Phase 2
Completed	`NCT02406209` - A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis	Phase 2
Not yet recruiting	`NCT04426734` - Evaluation of DEXTENZA in the Management of Pain and Inflammation in Patients With Anterior Uveitis Compared to Standard of Care Topical Corticosteroids	Phase 4
Completed	`NCT04222712` - A Study to Evaluate TRS01 Eye Drops in Participants With Active Non-infectious Anterior Uveitis	Phase 1/Phase 2